• Nicolas Destefanis, Improving Prognostic Models for Prostate Cancer: Integrating Clinical and Computational Approaches in the TPCP Cohort. Ph.D. Programme in Biomedical Sciences and Oncology XXXVII Cycle, febbraio 2026

• Lianas L, Del Rio M, Pireddu L, Aspegren O, Giunchi F, Fiorentino M, Leo S, Zelic R, Vincent PH, Destefanis N, Zugna D, Richiardi L, Pettersson A, Akre O, Frexia F. An open-source platform for structured annotation and computational workflows in digital pathology research. Scientific reports, agosto 2025

• Zelic R, Westerberg M, Stattin P, Garmo H, Richiardi L, Akre O, Pettersson A. Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Prostate Cancer–specific Death in Sweden: A Population-based Cohort Study. European Urology Open Science, luglio 2025

• Nicolas Destefanis, Variational Autoencoders per l’Estrazione di  Caratteristiche Istopatologiche nella Prognosi del Tumore alla Prostata, XLIX Convegno Associazione Italiana di Epidemiologia, aprile 2025

• Davide Musto, Un approccio integrato per il miglioramento della prognosi del tumore alla prostata: i marcatori molecolari di metilazione, XLIX Convegno Associazione Italiana di Epidemiologia, aprile 2025

• Nicolas Destefanis, Aggiornamento dei migliori modelli di prognosi per il tumore alla prostata metastatico in una coorte italiana, XLVIII Convegno Associazione Italiana di Epidemiologia, aprile 2024

• Nicolas Destefanis, Lorenzo Richiardi. Technical report "Tumore della prostata metastatico in Regione Piemonte", novembre 2023

• Destefanis N, Fiano V, Milani L, Vasapolli P, Fiorentino M, Giunchi F, Lianas L, Del Rio M, Frexia F, Pireddu L, Molinaro L, Cassoni P, Papotti MG, Gontero P, Calleris G, Oderda M, Ricardi U, Iorio GC, Fariselli P, Isaevska E, Akre O, Zelic R, Pettersson A, Zugna D, Richiardi L. Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort. Frontiers in Oncology, ottobre 2023

• Nicolas Destefanis, Un approccio integrato per il miglioramento della prognosi del tumore alla prostata: obiettivi, metodi e primi risultati della coorte TPCP, XLVII Convegno Associazione Italiana di Epidemiologia, aprile 2023

Pubblicazioni di riferimento per la coorte TPCP prodotte dal gruppo di lavoro dello studio Turin Prostate Cancer Prognostication. 

• Zelic R, Giunchi F, Fridfeldt J, et al. Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade. Clin Epidemiol 2022 Jan 18;14:59-70. doi: 10.2147/CLEP.S339140. eCollection 2022

• Zelic R, Giunchi F, Lianas L, et al. Interchangeability of light and virtual microscopy for histopathological evaluation of prostate cancer. Sci Rep 2021; 11: 3257. PMID: 33547336

• Zelic R, Garmo H, Zugna D, et al. Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study. Eur Urol 2020; 77: 180–188. doi:10.1016/j.eururo.2019.09.027. PMID: 31606332 (IF 17.947)

• Zelic R, Zugna D, Bottai M, et al. Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study. Am J Epidemiol 2019;188:1165-1173

• Fiano V, Zugna D, Grasso C, et al. DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer. Clin Epigenetics. 2019;11:152

• Carlsson J, Davidsson S, Fridfeldt J, et al. Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies. BMC Med Res Methodol 2018;18:161

• Zelic R, Fiano V, Ebot EM, et al. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality. Prostate Cancer Prostatic Dis. 2018

• Fiano V, Zugna D, Grasso C, et al. LINE-1 methylation status in prostate cancer and non-neoplastic tissue adjacent to tumor in association with mortality. Epigenetics 2017; 12: 11-18

• Zelic R, Fiano V, Zugna D, et al. Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy. Clin Cancer Res 2016; 15 ;22: 984-92

• Grasso C, Trevisan M, Fiano V, et al. Performance of Different Analytical Software Packages in Quantification of DNA Methylation by Pyrosequencing. PLoS One 2016; 11: e0150483

• Zelic R, Fiano V, Grasso C, et al. Global DNA hypomethylation in prostate cancer development and progression: a systematic review. Prostate Cancer Prostatic Dis 2015;18:1-12